Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01344616 · ClinicalTrials.gov registry record · Phase 2

Reducing Preterm Births in Underserved Pregnant Women

A Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams, sponsored by PHCC.

Completed
Registry status
Phase 2
Development phase
482
Enrollment target
1
Study location

NCT01344616: Completed Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams, sponsored by PHCC.

NCT01344616 is a Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams that has completed, run by PHCC. The registered enrollment target is 482 participants, below the 4,397-participant average among 39 other Preterm Birth trials with a reported enrollment target (89% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01344616, a Phase 2 study of Preterm Birth and Low Birth Weight <2500 Grams, has completed, sponsored by PHCC.

COMPLETED
Registry status
Phase 2
Development phase
482 participants
Enrollment target
1
Study location

Study Summary

Timely screening and management of modifiable conditions can reduce preterm births, yet providing effective prenatal risk management systems to meet the unique needs of medically underserved populations is complex. If the proposed system proves to be effective in reducing preterm births it can improve maternal and child quality of life as well as reduce the economic burden of preterm births in the U.S.

Primary Outcome

Birth weight \< 2500 grams

Interventions

  • BEHAVIORAL lifestyle support

Study Locations (1)

Colorado

  • PHCC LP - Pueblo

Trial Details

FieldValue
Enrollment Target 482 participants
Start Date 2010-08
Est. Completion 2013-10
Phase Phase 2
PHCC

2 total trials

What the finished NCT01344616 record still lists

NCT01344616 is an interventional study that assigns participants to a tested intervention. The registered 482 participants enrollment target is mid-sized for trials with a published cap, below the 4,397-participant average among 39 other Preterm Birth trials with a reported enrollment target (89% lower).

The record links to 3 conditions, with Preterm Birth appearing as the primary indexed condition, and to 1 intervention - of which lifestyle support is the first listed.

NCT01344616 reports a single indexed study location in Colorado.

Frequently Asked Questions

What is clinical trial NCT01344616 about?

NCT01344616 is a clinical study titled "Reducing Preterm Births in Underserved Pregnant Women". Timely screening and management of modifiable conditions can reduce preterm births, yet providing effective prenatal risk management systems to meet the unique needs of medically underserved populations is complex. If the proposed system proves to be effective in reducing preterm births it can impro...

What is the current status of trial NCT01344616?

This trial is currently completed. It is a Phase 2 study. The enrollment target is 482 participants. The study started on 2010-08. Estimated completion is 2013-10.

What conditions does trial NCT01344616 study?

This clinical trial studies the following conditions: Preterm Birth, Low Birth Weight <2500 Grams, Verylow Birthweight <1500 Grams.

What interventions are being tested in trial NCT01344616?

The interventions under investigation include: lifestyle support (BEHAVIORAL).

Who is sponsoring clinical trial NCT01344616?

This trial is sponsored by PHCC, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01344616 being conducted?

This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Preterm Birth

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01344616's enrollment target sits among peer trials

482 14th of 39 higher than 26 of 39 other Preterm Birth trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Preterm Birth trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04449458 · 482 participants · NA

    The Positively Quit Trial for Smoking Cessation

  • NCT07079631 · 482 participants · Phase 1

    A Clinical Study to Test if an Investigational Treatment Called BNT314 When Used in Combination With Another Investigational Treatment BNT327 and Chemotherapy, is Beneficial and Safe for Patients With Advanced Colorectal Cancer

  • NCT02871726 · 483 participants · NA

    Transrectal Ultrasound Robot-Assisted Prostate Biopsy

  • NCT05421741 · 484 participants · Phase 4

    Prophylactic Antibiotic Coated Nail to Prevent Infection: A Clinical Trial

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01344616, the US trial registry maintained by the National Library of Medicine. NCT01344616 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.